Gastro-protective strategies in primary care in Italy: The "Gas.Pro." survey

Digestive and Liver Disease

Volumn 42, Issue 5, 2010, Pages 359-364

  Bianco, Maria A ^a   Rotondano, Gianluca ^a   Buri, Luigi ^b   Tessari, Francesco ^c   Cipolletta, Livio ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c CED IDEA 99 srl Padova   (Italy)

Author keywords

Drug related GI injury; Gastro protection; Preventive strategies; Primary care

Indexed keywords

ACETYLSALICYLIC ACID; ALGINIC ACID; ANTACID AGENT; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; IBUPROFEN; KETOPROFEN; LANSOPRAZOLE; LOW MOLECULAR WEIGHT HEPARIN; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PANTOPRAZOLE; PROSTAGLANDIN DERIVATIVE; SEROTONIN UPTAKE INHIBITOR; STEROID; SUCRALFATE; TICLOPIDINE; WARFARIN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; DRUG ABUSE; FEMALE; GASTROINTESTINAL DISEASE; HEALTH SURVEY; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; ITALY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; OBSERVATIONAL STUDY; OUTPATIENT CARE; PHYSICIAN ATTITUDE; PRESCRIPTION; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; QUESTIONNAIRE; STOMACH PROTECTION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CROSS-SECTIONAL STUDIES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; ITALY; MALE; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, FAMILY; PROTON PUMP INHIBITORS;

EID: 77951641208     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2009.11.003     Document Type: Article

References (23)

1. Lazzaroni M., Bianchi Porro G. Prophylaxis and treatment of non-steroidal anti-inflammatory drug-induced upper gastrointestinal side-effects. Dig Liver Dis 2001, 33(Suppl. 2):S44-58.
2. García Rodríguez L.A., Barreales Tolosa L. Risk of upper gastrointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 2007, 132:498-506.
3. Lazzaroni M., Porro G.B. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors. Drugs 2009, 69:51-69.
4. Targownik L.E., Bolton J.M., Metge C.J., et al. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol 2009, 104:1475-1482.
5. Lazzaroni M., Battocchia A., Bianchi Porro G. COXIBs and non-selective NSAIDs in the gastroenterological setting: what should patients and physicians do?. Dig Liver Dis 2007, 39:589-596.
6. Targownik L.E., Metge C.J., Leung S. Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications. Aliment Pharmacol Ther 2008, 28:88-96.
7. American Gastroenterological Association, Wilcox C.M., Allison J., et al. Consensus development conference on the use of nonsteroidal anti-inflammatory agents, including cyclooxygenase-2 enzyme inhibitors and aspirin. Clin Gastroenterol Hepatol 2006, 4:1082-1089.
8. Chan F.K., Abraham N.S., Scheiman J.M., et al. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the first international working party on gastrointestinal and cardiovascular effects of nonsteroidal anti-inflammatory drugs and anti-platelet agents. Am J Gastroenterol 2008, 103:2908-2918.
9. Bhatt D.L., Scheiman J., Abraham N.S. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Am J Gastroenterol 2008, 103:2890-2907.
10. Lanza F.L., Chan F.K., Quigley E.M. Practice Parameters Committee of the American College of Gastroenterology. Guidelines for prevention of NSAID-related ulcer complications. Am J Gastroenterol 2009, 104:728-738.
11. Rostom A., Moayyedi P., Hunt R. Canadian consensus guidelines on long-term nonsteroidal anti-inflammatory drug therapy and the need for gastroprotection: benefits versus risks. Aliment Pharmacol Ther 2009, 29:481-496.
12. Elnachef N., Scheiman J.M., Fendrick A.M., et al. Changing perceptions and practices regarding aspirin, nonsteroidal anti-inflammatory drugs, and cyclooxygenase-2 selective nonsteroidal anti-inflammatory drugs among US primary care providers. Aliment Pharmacol Ther 2008, 28:1249-1258.
13. Johnell K., Fastbom J. Concomitant use of gastroprotectiove drugs among elderly NSAID/COX-2 selective inhibitor users: a nationwide register-based study. Clin Drug Investig 2008, 28:687-695.
14. Abraham N.S., El-Serag H.B., Johnson M.L., et al. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 2005, 129:1171-1178.
15. Goldstein J.L., Howard K.B., Walton S.M., et al. Impact of adherence to concomitant gastroprotective therapy on nonsteroidal-related gastroduodenal ulcer complications. Clin Gastroenterol Hepatol 2006, 4:1337-1345.
16. Van der Linden M.W., Gaugris S., Kuipers E.J., et al. Gastroprotection among new chronic users of non-steroidal anti-inflammatory drugs: a study of utilization and adherence in The Netherlands. Curr Med Res Opin 2009, 25:195-204.
17. Lanas A. Prevention of aspirin-induced gastroduodenal damage: H. pylori infection eradication versus proton pump inhibitors or both. Dig Liver Dis 2004, 36:655-657.
18. Ray W.A., Chung C.P., Stein C.M., et al. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Gastroenterology 2007, 133:790-798.
19. Abraham N.S., Castillo D.L., Hartman C. National mortality following upper gastrointestinal or cardiovascular events in older veterans with recent nonsteroidal anti-inflammatory drug use. Aliment Pharmacol Ther 2008, 28:97-106.
20. Targownik L.E., Metge C.J., Leung S., et al. The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs. Gastroenterology 2008, 134:937-944.
21. Bianchi Porro G., Lazzaroni M., Imbesi V., et al. Efficacy of pantoprazole in the prevention of peptic ulcers, induced by non-steroidal anti-inflammatory drugs: a prospective, placebo-controlled, double-blind, parallel-group study. Dig Liver Dis 2000, 32:201-208.
22. Juurlink D.N., Gomes T., Ko D.T., et al. A population-based study of the drug interaction between proton pump inhibitors and clopidogrel. CMAJ 2009, 180:713-718.
23. Siller-Matula J.M., Spiel A.O., Lang I.M., et al. Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel. Am Heart J 2009, 157. 148.e1-5.